Olea europaea leaf extract alters microRNA expression in human glioblastoma cells
- 22 June 2012
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 138 (11) , 1831-1844
Abstract
Glioblastoma multiforme (GBM) is the most common and the most lethal form of primary malignant tumors in the central nervous system. There is an increasing need for the development of more efficient therapeutic approaches for the treatment of these patients. One of the most attractive cancer therapy methods to date is the induction of tumor cell death by certain phytochemicals. Interestingly, bioactive compounds have been shown to alter micro RNA (miRNA) expression involved in several biological processes at the posttranscriptional level. The present study aimed to evaluate whether Olea europaea leaf extract (OLE) has an anticancer effect and modulates miRNA expression in GBM. Firstly, the anti-proliferative activity of OLE and the nature of the interaction with temozolomide (TMZ) of OLE were tested in human glioblastoma cell line T98G cells by trypan blue and WST-1 assays and than realized miRNA PCR array analysis. Potential mRNA targets were analyzed bioinformatically. OLE exhibited anti-proliferative effects on T98G cell lines. Cells were treated with temozolomide (TMZ) in the presence OLE, and changes to miRNA expression levels were identified by PCR array analysis. miRNA target genes are involved in cell cycle and apoptotic pathways. Specifically, miR-181b, miR-153, miR-145, miR-137, and let-7d were significantly upregulated after treatment with both TMZ and OLE. Our results suggest that OLE modulates the expression of some miRNAs related to anticancer activity in GBM and the response to TMZ. Further studies and validations are needed, but we suggest that OLE might be used for in vivo studies and future medical drug studies.Keywords
This publication has 63 references indexed in Scilit:
- Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potentialEuropean Journal of Pharmacology, 2012
- Proanthocyanidins Modulate MicroRNA Expression in Human HepG2 CellsPLOS ONE, 2011
- The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysisBMC Genomics, 2011
- Roles of small RNAs in tumor formationTrends in Molecular Medicine, 2010
- MicroRNAs and Their Therapeutic Potential for Human Diseases: PrefaceJournal of Pharmacological Sciences, 2010
- Diet, Epigenetic, and Cancer Prevention2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Induction of Growth Inhibition and Differentiation of Human Leukemia HL-60 Cells by a Tunisian Gerboui Olive Leaf ExtractBioscience, Biotechnology, and Biochemistry, 2007
- Plants as a source of anti-cancer agentsJournal of Ethnopharmacology, 2005
- Health-promoting properties of common herbsThe American Journal of Clinical Nutrition, 1999